ChiCTR2000039133
结束
/
/
/
2020-10-18
/
/
精神分裂症
Randomized controlled trial of Enhancing Contact Model on reducing stigma of mental illness in family caregivers of persons with schizophrenia in rural China
Randomized controlled trial of Enhancing Contact Model on reducing stigma of mental illness in family caregivers of persons with schizophrenia in rural China
The study tests the short (post- intervention) and long-term (9-month follow-up) effectiveness of a newly developed Enhancing Contact Model (ECM) Intervention for reducing self-stigma in family caregivers of persons with schizophrenia, and examines whether ECM is more effective on reducing self-stigma than Psychoeducational Family Intervention (PFI).
随机平行对照
其它
Computer generated numbers for randomization
Not stated
Research Grants Council, University Grants Committee, General Research Fund
/
88;84;97
/
2018-09-01
2021-02-28
/
The inclusion criteria for family caregivers: 1. Being the father or mother of a person with schizophrenia identified in 2015; 2. Aged 38- 75 years; 3. Living together with and caring for the patient; 4. Not participants in our prior PFI studies; 5. Be able to provide written informed consent. The inclusion criteria for person with schizophrenia: 1. Be identified in the 2015 survey; 2. Aged >=18 years; 3. Not participants in our prior PFI studies.；
登录查看The exclusion criteria for the family caregivers: 1. likely to engage in a risk behavior (e.g., suicide or violence) imminently; 2. Be identified by a trained health professional as unsuitable to join the study (e.g., with mental illness).；
登录查看香港大學社會科學學院
/
昌郁医药2024-11-22
上海和誉生物医药科技有限公司2024-11-22
云顶新耀2024-11-22
金斯瑞生物2024-11-22
细胞与基因治疗领域2024-11-22
肝脏时间2024-11-22
医药笔记2024-11-22
生物安全情报网2024-11-22
医药速览2024-11-22
亚盛医药2024-11-22
浙公网安备33011002015279
本网站未发布麻醉药品、精神药品、医疗用毒性药品、放射性药品、戒毒药品和医疗机构制剂的产品信息
友情链接: 摩熵医药 摩熵医药企业版 摩熵化学MolAid 晓材Matmole 摩熵医学MedXYZ 载体质粒 觅健肿瘤互助 动脉网 药物百科
